<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Alps Group Inc — News on 6ix</title>
    <link>https://6ix.com/company/alps-group-inc</link>
    <description>Latest news and press releases for Alps Group Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 17 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/alps-group-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d7325051cc36e47532d3b8.webp</url>
      <title>Alps Group Inc</title>
      <link>https://6ix.com/company/alps-group-inc</link>
    </image>
    <item>
      <title>Alps Group Appoints Former Ernst &amp; Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight</title>
      <link>https://6ix.com/company/alps-group-inc/news/alps-group-appoints-former-ernst-and-young-partner-to-board-of-directors-strengthening-governance-and-capital-markets-oversight</link>
      <guid isPermaLink="true">https://6ix.com/company/alps-group-inc/news/alps-group-appoints-former-ernst-and-young-partner-to-board-of-directors-strengthening-governance-and-capital-markets-oversight</guid>
      <pubDate>Fri, 17 Apr 2026 04:00:00 GMT</pubDate>
      <description>KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc.</description>
    </item>
    <item>
      <title>Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy</title>
      <link>https://6ix.com/company/alps-group-inc/news/alps-group-inc-announces-potential-pipeline-expansion-beyond-celesome-following-publication-of-nebulized-human-umbilical-cord-mesenchymal-stem-cell-exosome-therapy</link>
      <guid isPermaLink="true">https://6ix.com/company/alps-group-inc/news/alps-group-inc-announces-potential-pipeline-expansion-beyond-celesome-following-publication-of-nebulized-human-umbilical-cord-mesenchymal-stem-cell-exosome-therapy</guid>
      <pubDate>Fri, 30 Jan 2026 13:00:00 GMT</pubDate>
      <description>KUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a potential expansion of its exosome-related pipeline beyond its previously disclosed CELESOME(+) program. The announcement follows the publication of a preliminary retrospective clinic</description>
    </item>
    <item>
      <title>Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer</title>
      <link>https://6ix.com/company/alps-group-inc/news/alps-group-inc-appoints-cheing-lye-ping-as-chief-financial-officer</link>
      <guid isPermaLink="true">https://6ix.com/company/alps-group-inc/news/alps-group-inc-appoints-cheing-lye-ping-as-chief-financial-officer</guid>
      <pubDate>Thu, 08 Jan 2026 05:00:00 GMT</pubDate>
      <description>KUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ: ALPS) (the “Company” or “Alps Group”), a fully integrated biotechnology</description>
    </item>
    <item>
      <title>Alps Announces Closing of Business Combination with Globalink Investment Inc.</title>
      <link>https://6ix.com/company/alps-group-inc/news/alps-announces-closing-of-business-combination-with-globalink-investment-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/alps-group-inc/news/alps-announces-closing-of-business-combination-with-globalink-investment-inc</guid>
      <pubDate>Fri, 31 Oct 2025 12:00:00 GMT</pubDate>
      <description>Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” on October 31, 2025KUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, and Globalink Investment Inc., a Delaware corporation and a special purpose acquisition company (“</description>
    </item>
  </channel>
</rss>